We fabricate a drug-delivery system (MDS) through bioactivated in vivo self-assembly (BIVA) nanotechnology. The percentage of solvent-exposed surface area (%SASA) MDS assembling modular, as well its non-covalent interaction between four other modules synergetically decide the stable conformation and modulate situ assembly. Our will benefit further drug delivery to prolong retention accumulation.

Heterogeneous single-site catalysts consist of isolated, well-defined, active sites that are spatially separated in a given solid and, ideally, structurally identical. In this review, the potential of metal-organic frameworks (MOFs) and covalent organic frameworks (COFs) as platforms for the development of heterogeneous single-site catalysts is reviewed thoroughly. In the first part of this art...